Skip to main content
. 2014 Sep 29;9(9):e108480. doi: 10.1371/journal.pone.0108480

Table 1. Clinicopathologic features of patients with and without SHLNM.

SPHLN
Parameter All patients (n = 346) Non-metastasis (n = 311) Metastasis (n = 35) p value
Age, yr
≤60 155 137 18 0.405
>60 191 174 17
Sex
Male 267 239 28 0.674
Female 79 72 7
BMI, kg/m2
<25 302 273 29 0.407
≥25 44 38 6
Histology
undifferentiated 198 175 23 0.529
mix 66 60 6
differentiated 82 76 6
Location
Lesser 256 246 10 <0.001
Greater 22 18 4
Anterior 5 3 2
Posterior 17 12 5
Circum 46 32 14
Size (cm)
<5.5 180 174 6 <0.001
≥5.5 166 137 29
LVI
LVI(−) 186 172 14 0.540
LVI(+) 160 139 21
CA199(U/mL)
≤37 293 268 25 0.043
>37 53 43 10
Surgery
LAPG 4 4 0 0.500
LATG 342 307 35
UICC(n)
IA 27 27 0 <0.001
IB 18 18 0
IIA 43 43 0
IIB 40 40 0
IIIA 47 45 2
IIIB 71 66 5
IIIC 100 72 28
Depth
pT1 35 35 0 <0.001
pT2 26 26 0
pT3 132 128 4
pT4 153 122 31
LNM
pN0 87 87 0 <0.001
pN1 51 50 1
pN2 61 56 5
pN3 147 118 29
Number of SPHLNs 2.69±2.76 2.56±±2.80 4.03±2.49 0.003
Number of dissection 41.44±15.45 41.55±15.81 40.40±11.93 0.676
No.1 76(346) 63(311) 13(35) 0.022
No.2 79(346) 61(311) 18(35) <0.001
No.3 235(346) 202(311) 33(35) <0.001
No.4 81(346) 60(311) 21(35) <0.001
No.5 30(346) 24(311) 6(35) 0.074
No.6 48(346) 38(311) 10(35) 0.008
No.7 140(346) 112(311) 28(35) 0.001
No.8 54(346) 42(311) 12(35) 0.001
No.9 86(346) 69(311) 17(35) 0.001
No.11 60(346) 42(311) 18(35) <0.001
No.12 43(346) 34(311) 9(35) 0.012

Circum, includes more than 2 portions and circum patients; BMI, body mass index; LVI, lymphovascular invasion; LNM, lymph nodes metastasis.

No.1(Right cardial), No.2(Left cardial), No.3(LN along the lesser curvature ), No.4(LN along the greater curvature), No.5(Suprapyloric), No.6 (Infrapyloric), No.7(LN along the left gastric artery), No.8(LN along the common hepatic artery), No.9(LN along the celiac artery), No.11(LN along the splenic artery ), No.12(LN in the hepatoduodenal ligament ).